TCR-NK therapy

OSLO, Norway, July 13, 2026 Zelluna announced that the first patient has been dosed in the ZIMA-101 Phase 1...

OSLO, Norway, May 6, 2026 Zelluna ASA announced the activation of the first clinical site for its ZIMA-101 Phase...